Full text is available at the source.
Abstract
Estrogens may exert neuroprotective effects on cognitive aging, but clinical data on menopausal estrogen therapy remain unclear.
- Preclinical models indicate that estrogens are associated with neuroprotection and improved cognitive aging.
- Clinical evidence regarding the benefits of menopausal estrogen therapy for brain health is mixed.
- Cardiometabolic disease may influence how estrogens affect cognitive decline, potentially reducing their protective effects.
- Mechanisms suggested include alterations in estrogen actions on both brain memory systems and cardiometabolic systems.
- Exploring how estrogen effects vary by health status aligns with the goals of precision medicine.
- Understanding estrogen impacts in different aging models is essential for bridging preclinical findings with clinical applications.
Simplified